Detalhe da pesquisa
1.
Combined Dusp4 and p53 loss with Dbf4 amplification drives tumorigenesis via cell cycle restriction and replication stress escape in breast cancer.
Breast Cancer Res
; 24(1): 51, 2022 07 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35850776
2.
Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: an open-label, multi-arm, non-randomised, multicentre, phase 2 trial.
Lancet Oncol
; 22(6): 883-892, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33989559
3.
PIK3CA and MAP3K1 alterations imply luminal A status and are associated with clinical benefit from pan-PI3K inhibitor buparlisib and letrozole in ER+ metastatic breast cancer.
NPJ Breast Cancer
; 5: 31, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31552290
4.
USP11 Enhances TGFß-Induced Epithelial-Mesenchymal Plasticity and Human Breast Cancer Metastasis.
Mol Cancer Res
; 16(7): 1172-1184, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29724812